Rallybio Corporation (RLYB)
NASDAQ: RLYB · IEX Real-Time Price · USD
1.770
-0.090 (-4.84%)
May 17, 2024, 4:00 PM EDT - Market closed
Rallybio Stock Forecast
RLYB's stock price has decreased by -68.62% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Rallybio stock have an average target of 8.90, with a low estimate of 1.50 and a high estimate of 15. The average target predicts an increase of 402.82% from the current stock price of 1.77.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Rallybio stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 0 | 0 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +408.47% | May 10, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $8 | Buy | Reiterates | $8 | +351.98% | Apr 19, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $8 | Buy | Reiterates | $8 | +351.98% | Apr 18, 2024 |
| Wedbush | Wedbush | Buy Maintains $13 → $11 | Buy | Maintains | $13 → $11 | +521.47% | Apr 11, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.60
from -1.84
EPS Next Year
-1.48
from -1.60
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 194.7M | 649.4M |
| Avg | n/a | n/a | n/a | 189.1M | 630.9M |
| Low | n/a | n/a | n/a | 181.7M | 606.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 243.4% |
| Avg | - | - | - | - | 233.6% |
| Low | - | - | - | - | 220.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.11 | -0.85 | -0.80 |
| Avg | -1.60 | -1.48 | -1.42 |
| Low | -2.07 | -2.05 | -2.27 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.